Tommy Rampling
Overview
Explore the profile of Tommy Rampling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
2717
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alvi M, Kliner M, Welfare W, Gordon N, Thomas S, Padfield S, et al.
Euro Surveill
. 2025 Mar;
30(10).
PMID: 40084422
We report two importations of monkeypox virus clade Ib infection to the United Kingdom in 2024. The first was a traveller returning from Tanzania, Rwanda and Uganda, the second from...
2.
Callaby H, Beard K, Wakerley D, Lake M, Osborne J, Brown K, et al.
Euro Surveill
. 2025 Feb;
30(5).
PMID: 39916608
BackgroundTick-borne encephalitis virus (TBEV) is a flavivirus spread by ticks and can cause tick-borne encephalitis (TBE) in humans. Previously, TBE has been reported in returning travellers in the United Kingdom...
3.
Jones S, Hicks B, Callaby H, Bailey D, Gordon N, Rampling T, et al.
Lancet Microbe
. 2025 Jan;
100987.
PMID: 39832516
Background: In May, 2022, the first global outbreak of mpox (formerly known as monkeypox) occurred. In response, public health agencies in the UK have made smallpox vaccines available to individuals...
4.
Barrett J, Muntengesa E, Warrell C, Rampling T, Owen J, Patel D, et al.
J Antimicrob Chemother
. 2025 Jan;
80(3):825-827.
PMID: 39821333
Objectives: Yellow fever-associated viscerotropic disease (YEL-AVD) is a rare but serious complication arising from administration of live-attenuated yellow fever vaccine to individuals with risk factors such as thymectomy. At present...
5.
McBride A, Longley N, Osborne J, Rampling T, Houlihan C
Lancet Microbe
. 2024 Dec;
:101054.
PMID: 39730006
No abstract available.
6.
Callaby H, Olver J, Emery K, Richards K, Killip M, Groves N, et al.
Lancet Infect Dis
. 2024 Dec;
25(1):e4-e5.
PMID: 39617024
No abstract available.
7.
Hicks B, Jones S, Callaby H, Bailey D, Gordon C, Rampling T, et al.
Vaccine
. 2024 Oct;
42(26):126453.
PMID: 39426286
Background: The 2022 Monkeypox virus (MPXV) global outbreak boosted development of multiple serological assays to aid understanding of Mpox immunology. Objectives: The study aimed to assess a multiplexed solid-phase electrochemiluminescence...
8.
Thompson A, Brooks T, Houlihan C, Rampling T, Umpleby H, Hansford K, et al.
Emerg Infect Dis
. 2024 Sep;
30(10):2188-2190.
PMID: 39320338
Tularemia, caused by Francisella tularensis, is not known to occur in the United Kingdom. We report a case of tularemia diagnosed in July 2023 in a UK patient with no...
9.
Warrell C, Chaudhry Z, Shawe-Taylor M, Mastoraki E, Delmonte Sen A, Rafferty H, et al.
Open Forum Infect Dis
. 2024 Aug;
11(8):ofae413.
PMID: 39113827
Background: To report on the implementation and outcomes of a virtual ward established for the management of mpox during the 2022 outbreak, we conducted a 2-center, observational, cross-sectional study over...
10.
Callaby H, McGuire E, Rajwal S, Stahlschmidt J, Hartley J, Brown R, et al.
J Pediatr Gastroenterol Nutr
. 2024 Feb;
78(3):534-538.
PMID: 38327256
In 2022, there were global reports of increased numbers of acute hepatitis not explained by hepatitis A-E virus infection in children. This manuscript summarises histopathology results from 20 patients in...